Gujarat Terce Laboratories Limited (GUJTERC.BO)
INR 71.5
(0.0%)
INR 71.5
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 8.99 Million INR | 143.3% |
| 2022 | -20.76 Million INR | -343.09% |
| 2021 | 8.54 Million INR | 131.11% |
| 2020 | -27.45 Million INR | -700.77% |
| 2019 | 4.56 Million INR | 60.46% |
| 2018 | 2.84 Million INR | 93.63% |
| 2017 | 1.47 Million INR | 246.95% |
| 2016 | -1 Million INR | -279.02% |
| 2015 | -264.04 Thousand INR | -103.48% |
| 2014 | 7.58 Million INR | 20.07% |
| 2013 | 6.31 Million INR | -4.71% |
| 2012 | 6.63 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -3.53 Million INR | -780.38% |
| 2023 FY | 8.99 Million INR | 143.3% |
| 2023 Q4 | 7.56 Million INR | 67.63% |
| 2023 Q3 | 4.51 Million INR | 137.02% |
| 2023 Q2 | -12.18 Million INR | -244.38% |
| 2022 Q3 | -4.73 Million INR | 72.96% |
| 2022 Q1 | -18.05 Million INR | -408.61% |
| 2022 Q4 | 520 Thousand INR | 110.98% |
| 2022 Q2 | -17.51 Million INR | 3.0% |
| 2022 FY | -20.76 Million INR | -343.09% |
| 2021 Q3 | 4.83 Million INR | -69.41% |
| 2021 Q1 | -24.72 Million INR | -3140.76% |
| 2021 FY | 8.54 Million INR | 131.11% |
| 2021 Q4 | 5.85 Million INR | 21.11% |
| 2021 Q2 | 15.79 Million INR | 163.87% |
| 2020 Q3 | 631 Thousand INR | 113.7% |
| 2020 FY | -27.45 Million INR | -700.77% |
| 2020 Q2 | -4.6 Million INR | 18.83% |
| 2020 Q4 | -763 Thousand INR | -220.92% |
| 2020 Q1 | -5.67 Million INR | -243.18% |
| 2019 Q2 | -11.69 Million INR | -1765.12% |
| 2019 FY | 4.56 Million INR | 60.46% |
| 2019 Q1 | 702.59 Thousand INR | -88.53% |
| 2019 Q3 | 17.82 Million INR | 252.37% |
| 2019 Q4 | 3.96 Million INR | -77.76% |
| 2018 Q4 | 6.12 Million INR | 230.83% |
| 2018 FY | 2.84 Million INR | 93.63% |
| 2018 Q3 | 1.85 Million INR | 131.21% |
| 2018 Q2 | -5.93 Million INR | -201.74% |
| 2018 Q1 | -1.96 Million INR | -153.88% |
| 2017 Q1 | -1.56 Million INR | -504.39% |
| 2017 Q3 | 11.24 Million INR | 185.21% |
| 2017 Q4 | 3.65 Million INR | -67.54% |
| 2017 Q2 | -13.19 Million INR | -743.32% |
| 2017 FY | 1.47 Million INR | 246.95% |
| 2016 FY | -1 Million INR | -279.02% |
| 2016 Q3 | 10.67 Million INR | 215.01% |
| 2016 Q4 | 387 Thousand INR | -96.37% |
| 2016 Q2 | -9.27 Million INR | -188.32% |
| 2016 Q1 | 10.5 Million INR | 389.5% |
| 2015 Q4 | -3.62 Million INR | -57.1% |
| 2015 FY | -264.04 Thousand INR | -103.48% |
| 2015 Q1 | 1.58 Million INR | 121.54% |
| 2015 Q2 | -6.7 Million INR | -523.63% |
| 2015 Q3 | -2.31 Million INR | 65.53% |
| 2014 Q1 | 2.36 Million INR | 1075.54% |
| 2014 FY | 7.58 Million INR | 20.07% |
| 2014 Q4 | 714 Thousand INR | -7.75% |
| 2014 Q3 | 774 Thousand INR | 245.76% |
| 2014 Q2 | -531 Thousand INR | -122.47% |
| 2013 Q1 | 1.73 Million INR | 38.73% |
| 2013 FY | 6.31 Million INR | -4.71% |
| 2013 Q3 | 2.47 Million INR | 226.08% |
| 2013 Q2 | -1.96 Million INR | -213.47% |
| 2013 Q4 | 201 Thousand INR | -91.88% |
| 2012 Q2 | 254 Thousand INR | 175.6% |
| 2012 Q4 | 1.24 Million INR | 6.95% |
| 2012 FY | 6.63 Million INR | 0.0% |
| 2012 Q1 | -336 Thousand INR | -282.61% |
| 2012 Q3 | 1.16 Million INR | 359.06% |
| 2011 Q3 | 3.3 Million INR | 0.0% |
| 2011 Q4 | 184 Thousand INR | -94.44% |
| 2010 Q1 | 2.22 Million INR | 0.0% |
| 2009 Q1 | -151 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 77.57 Million INR | 88.411% |
| Cian Healthcare Limited | 53.96 Million INR | 83.342% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 45.3% |
| Colinz Laboratories Limited | 14.64 Million INR | 38.605% |
| Denis Chem Lab Limited | 142.87 Million INR | 93.708% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 176.478% |
| Evoq Remedies Limited | 42.91 Million INR | 79.053% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 98.947% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 98.656% |
| MedPlus Health Services Limited | 1.31 Billion INR | 99.319% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 107.275% |
| PANJON LTD. | - INR | -Infinity% |
| PRAVEG LIMITED | 185.06 Million INR | 95.142% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 86.056% |
| Sastasundar Ventures Limited | -229.64 Million INR | 103.915% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 2314.286% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 90.889% |
| BDH Industries Limited | 169.01 Million INR | 94.681% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 83.271% |
| ANG Lifesciences India Limited | 12.8 Million INR | 29.793% |
| Veerhealth Care Limited | 34.19 Million INR | 73.707% |
| Zenith Healthcare Limited | 196 Thousand INR | -4486.735% |
| Zenlabs Ethica Limited | 89.27 Million INR | 89.93% |
| Zenotech Laboratories Limited | 242.37 Million INR | 96.291% |
| Crestchem Limited | 27.25 Million INR | 67.016% |
| Norris Medicines Limited | 11.15 Million INR | 19.424% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 96.195% |
| Sunil Healthcare Limited | -19.98 Million INR | 144.993% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 97.942% |
| Bacil Pharma Limited | -1.89 Million INR | 574.572% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 97.532% |
| Patidar Buildcon Limited | -1.83 Million INR | 589.651% |
| Phaarmasia Limited | - INR | -Infinity% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 98.43% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 95.832% |
| Trimurthi Limited | -6.14 Million INR | 246.344% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 188.598% |
| Vivanza Biosciences Limited | 14.83 Million INR | 39.388% |
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -1590.485% |
| Anuh Pharma Limited | 682.19 Million INR | 98.682% |
| Beryl Drugs Limited | 14.73 Million INR | 38.976% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 105.616% |
| Deccan Health Care Limited | 185.32 Million INR | 95.149% |
| Godavari Drugs Limited | -67.67 Million INR | 113.285% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -12.826% |
| Kerala Ayurveda Limited | 48.04 Million INR | 81.289% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 123.81% |
| Lactose (India) Limited | 137.78 Million INR | 93.475% |
| Makers Laboratories Limited | -34.91 Million INR | 125.752% |
| Medi-Caps Limited | -17.21 Million INR | 152.237% |
| Mercury Laboratories Limited | 62.14 Million INR | 85.535% |
| Parmax Pharma Limited | 3.75 Million INR | -139.443% |
| Roopa Industries Limited | 48.05 Million INR | 81.293% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 73.679% |
| Syschem (India) Limited | 504.91 Million INR | 98.22% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 97.352% |
| Bharat Parenterals Limited | 733.49 Million INR | 98.774% |
| Trident Lifeline Limited | 72.21 Million INR | 87.55% |
| Concord Drugs Limited | 24.87 Million INR | 63.855% |
| Gennex Laboratories Limited | 146.61 Million INR | 93.868% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 150.176% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 85.329% |
| Parnax Lab Limited | 166.84 Million INR | 94.612% |
| Trinity League India Limited | 1.17 Million INR | -666.411% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 47.504% |
| Tyche Industries Limited | 111.22 Million INR | 91.917% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 98.205% |
| Transchem Limited | -17.43 Million INR | 151.551% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 106.021% |
| Panchsheel Organics Limited | 288.28 Million INR | 96.882% |
| Coral Laboratories Limited | 142.63 Million INR | 93.697% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 462.5% |
| Natural Capsules Limited | 112.4 Million INR | 92.002% |
| Auro Laboratories Limited | 95.77 Million INR | 90.613% |